MAR 23, 2016 4:40 PM PDT

Scientists Prove Certain Antidepressants Are Not Linked to Increased Risk for Cardiovascular Disease

WRITTEN BY: Kara Marker
While scientists believe people diagnosed with depression have an increased risk of developing cardiovascular disease, a new study from the University of Nottingham has provided substantial evidence showing certain antidepressants, called selective serotonin reuptake inhibitors (SSRIs) are not involved in that increased risk.
 
Cardiovascular disease is the leading cause of death for both men and women in the United States, and a leading killer worldwide. On the other hand, antidepressants are one of the most commonly prescribed drugs, so any preconceived connection between the two could cause a lot of problems.
 
In a study of 238,963 participants, all diagnosed with depression between 2000 and 2011, University of Nottingham researchers looked for the association between various antidepressants and cardiovascular outcomes. They monitored the participants, noting any occurrence of heart attack, stroke, transient ischemic attacks, or arrhythmia, and the study was recently published in the journal  BMJ.
 
In addition to examining patients taking SSRIs, they also looked at patients taking tricyclic drugs and others. They also considered the following factors:
  • Dosage
  • Duration of use
  • Age
  • Sex
  • Smoking
  • Alcohol consumption
  • Co-morbidities
  • Use of other drugs
The results showed double the risk for arrhythmia during the first four weeks of taking tricyclic and related antidepressants but no increased risk for patients taking SSRIs. In fact, patients prescribed SSRIs are possibly associated with a reduced risk of heart attack, particularly when taking a drug called fluoxetine, although the researchers are not positive about this relationship yet.
 
Another drug called citalopram, the most commonly prescribed antidepressant drug, showed no increased risk of heart disease even at the highest doses. However, the scientists still unsure if high doses of citalopram could potentially lead to increased risk for heart disease because only 18 percent of the study participants with citalopram prescriptions were for high doses, so they still recommend for doctors not to prescribe high doses of citalopram.
 

Source: University of Nottingham
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 10, 2020
Cardiology
Liposomal Delivery Could Help Prevent Doxorubicin Cardiotoxicity
NOV 10, 2020
Liposomal Delivery Could Help Prevent Doxorubicin Cardiotoxicity
One of the greatest failures of modern cancer therapies is the rather substantial off-target toxic effects many radio-, ...
DEC 03, 2020
Chemistry & Physics
3-D Printed, Realistic Heart Model for Training Future Physicians
DEC 03, 2020
3-D Printed, Realistic Heart Model for Training Future Physicians
Building a realistic tissue model is critical for training young physicians and surgeons, and yet challenging due to the ...
JAN 13, 2021
Cardiology
Short Bursts of Exercise Boost Markers of Good Health
JAN 13, 2021
Short Bursts of Exercise Boost Markers of Good Health
Exercise is good for our health, but it seems that certain kinds of exercise are more beneficial than others. Recent res ...
MAR 18, 2021
Cardiology
Searching for New Cardiovascular Biomarkers
MAR 18, 2021
Searching for New Cardiovascular Biomarkers
Do you want to know what the best medicine for cardiovascular health is? It isn't some heart-shaped pill with some m ...
MAR 25, 2021
Cardiology
Improved Triage Method to Get STEMI Patients from Door to Treatment
MAR 25, 2021
Improved Triage Method to Get STEMI Patients from Door to Treatment
A heart attack is an incredibly sudden and dangerous cardiac event that requires quick action for a successful recovery. ...
APR 13, 2021
Cardiology
Can a Ketosis Metabolite Act as a Biomarker for Cardiovascular Diseases?
APR 13, 2021
Can a Ketosis Metabolite Act as a Biomarker for Cardiovascular Diseases?
Quick and reliable diagnostics are the key to controlling many diseases, including cardiovascular disease. Biomarkers ar ...
Loading Comments...